User profiles for Juergen Prattes
 | Juergen PrattesMedical University of Graz Verified email at medunigraz.at Cited by 3943 |
[HTML][HTML] Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European …
J Prattes, J Wauters, DR Giacobbe… - Clinical Microbiology …, 2022 - Elsevier
Objectives Coronavirus disease 2019 (COVID-19) -associated pulmonary aspergillosis (CAPA)
has emerged as a complication in critically ill COVID-19 patients. The objectives of this …
has emerged as a complication in critically ill COVID-19 patients. The objectives of this …
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the …
With increasing numbers of patients needing intensive care or who are immunosuppressed,
infections caused by moulds other than Aspergillus spp or Mucorales are increasing. …
infections caused by moulds other than Aspergillus spp or Mucorales are increasing. …
The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin
The epidemiology of invasive fungal infections is changing, with new populations at risk and
the emergence of resistance caused by the selective pressure from increased usage of …
the emergence of resistance caused by the selective pressure from increased usage of …
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
Background Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA)
emerged as important fungal complications in patients with COVID-19-associated severe …
emerged as important fungal complications in patients with COVID-19-associated severe …
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
Viral infections can cause acute respiratory distress syndrome (ARDS), consequently leading
to susceptibility for secondary pulmonary infections. Over the past few weeks, a number of …
to susceptibility for secondary pulmonary infections. Over the past few weeks, a number of …
[HTML][HTML] Invasive pulmonary aspergillosis complicating COVID-19 in the ICU-A case report
It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report
a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), …
a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), …
Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases
J Prattes, H Flick, F Prüller, C Koidl… - American journal of …, 2014 - atsjournals.org
Rationale: Invasive pulmonary aspergillosis has been increasingly reported in nonneutropenic
patients, including those with underlying respiratory diseases. Objectives: We compared …
patients, including those with underlying respiratory diseases. Objectives: We compared …
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
…, M Narayanan, S Martín-Pérez, J Prattes… - The Lancet Infectious …, 2023 - thelancet.com
Background The European Confederation of Medical Mycology (ECMM) collected data on
epidemiology, risk factors, treatment, and outcomes of patients with culture-proven …
epidemiology, risk factors, treatment, and outcomes of patients with culture-proven …
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
In recent decades, important advances have been made in the diagnosis and treatment of
invasive aspergillosis (IA) and mucormycosis. One of these advances has been the …
invasive aspergillosis (IA) and mucormycosis. One of these advances has been the …
Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and …
S Heldt, J Prattes, S Eigl, B Spiess, H Flick… - Journal of Infection, 2018 - Elsevier
Background Aspergillus spp. induce elevated levels of several cytokines. It remains
unknown whether these cytokines hold value for clinical routine and enhance diagnostic …
unknown whether these cytokines hold value for clinical routine and enhance diagnostic …
